ResMed Inc.
RMD institutional ownership changes in Q2 2026: 134 institutions opened or added positions, 163 trimmed or exited. RMD (ResMed Inc.) is held by 286 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($2.4B), Vanguard Capital Management LLC ($1.8B), Vanguard Portfolio Management LLC ($1.5B). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Oct 26, 2026 · Activists Aug 7, 2026 · Congress Aug 5, 2026
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Increased | 12.3M(+1.9%) | $2.4B | 0.0% | -4.49% | 32 | |
Increased | 9.5M(+0.1%) | $1.8B | 0.0% | +1.76% | 32 | |
Increased | 7.9M(+0.6%) | $1.5B | 0.1% | +1.83% | 32 | |
Increased | 6.7M(+0.6%) | $1.3B | 0.0% | +56.57% | 32 | |
Decreased | 4.4M(-0.0%) | $845.2M | 0.0% | +39.41% | 0 | |
Decreased | 4.2M(-14.8%) | $818M | 0.1% | +23.28% | 0 | |
Increased | 2.3M(+48.2%) | $444.1M | 0.3% | -0.16% | 51 | |
Increased | 2.1M(+5.5%) | $402.1M | 0.0% | +32.85% | 33 | |
Decreased | 1.9M(-28.2%) | $375.9M | 0.0% | +8.77% | 0 | |
Decreased | 1.7M(-1.7%) | $330.6M | 0.0% | +61.68% | 0 | |
Increased | 1.4M(+34.3%) | $269.6M | 0.2% | +5.02% | 48 | |
Decreased | 1.3M(-7.1%) | $257.7M | 0.1% | +2.24% | 0 | |
Increased | 1.3M(+77.4%) | $251.3M | 0.0% | +5.49% | 47 | |
Decreased | 1.3M(-5.6%) | $248.5M | 0.2% | -16.14% | 0 | |
Increased | 1.2M(+7.7%) | $238.2M | 0.0% | +43.88% | 33 | |
Increased | 1.2M(+15.6%) | $226.1M | 0.0% | +12.26% | 35 | |
Increased | 1.1M(+150.9%) | $220.2M | 0.1% | +6.89% | 49 | |
Increased | 1.1M(+11.9%) | $219M | 0.0% | +24.95% | 34 | |
Decreased | 942,614(-4.8%) | $183.7M | 0.0% | +63.45% | 0 | |
Increased | 910,623(+160.3%) | $177.1M | 0.1% | +10.55% | 49 |
Showing 1-20 of 303
RMDResMed Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RMD
Who owns RMD?
286 institutional investors held RMD on June 30, 2026, led by BlackRock, Inc. ($2.4B), Vanguard Capital Management LLC ($1.8B) and Vanguard Portfolio Management LLC ($1.5B).
How many hedge funds hold RMD?
286 institutional investors reported RMD in their 13F filings for the quarter ended June 30, 2026, $17.5B in all. 11 of them are rated Elite.
Are institutions buying or selling RMD?
Selling, on balance. In Q2 2026, 163 institutions trimmed or exited RMD and 134 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer